CPMD
CANNAPHARMARX, INC.
Key Financials
Gross Profit
$-2084908
↑ 29.0%
Revenue
$1.4M
↑ 66.1%
Operating Income
$-3347764
↑ 7.2%
Net Income
$-11131448
↓ 12.4%
EPS (Diluted)
$-0.02
0.0%
Shareholders' Equity
$-30153729.00
↓ 52.2%
Total Liabilities
$37.2M
↑ 21.3%
Cash & Equivalents
$1804.00
↓ 16.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/20/2026 | View on SEC |
| NT 10-Q | 5/18/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 1/13/2026 | View on SEC |
| 8-K | 12/18/2025 | View on SEC |
| 10-Q | 11/14/2025 | View on SEC |
| 8-K | 10/10/2025 | View on SEC |
| 144 | 8/22/2025 | View on SEC |
| 10-Q | 8/14/2025 | View on SEC |
| 144 | 5/22/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CPMD |
| Company Name | CANNAPHARMARX, INC. |
| CIK | 1081938 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 949-652-6838 |